These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35557513)

  • 1. Efficacy of INtensive Treatment vs. Standard Treatment of COmpound DanshEn Dripping Pills in Refractory Angina Patients With Incomplete Revascularization (INCODER Study): Study Protocol for a Multicenter, Double-Blind, Randomized Controlled, Superiority Trial.
    Wu Z; Xu D; Wu Z; Chen A; Liu L; Ling L; Zhou Y; Liu D; Liu Y; Dong Y; Chen Y
    Front Cardiovasc Med; 2022; 9():860059. PubMed ID: 35557513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Compound Danshen Dripping Pills on Ventricular Remodeling and Cardiac Function after Acute Anterior Wall ST-Segment Elevation Myocardial Infarction (CODE-AAMI): Protocol for a Randomized Placebo-Controlled Trial.
    Wu YJ; Deng B; Wang SB; Qiao R; Zhang XW; Lu Y; Wang L; Gu SZ; Zhang YQ; Li KQ; Yu ZL; Wu LX; Zhao SB; Zhou SL; Yang Y; Wang LS
    Chin J Integr Med; 2023 Dec; 29(12):1059-1065. PubMed ID: 37656413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of
    Wu T; Li S; Li Z; Long W; Liu Q; Tang H; Huang X; Tang Y; Dong X; Ning Y; Tian S; Xu T; Xian SX; Liao H; Hong Y; Yang Z
    BMJ Open; 2023 May; 13(5):e055263. PubMed ID: 37164472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Jiuxin Pill in the Treatment of Patients with Stable Angina Pectoris: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
    Liu T; Zhang J; Zhao Z; Bi Y; Zheng Y; Wang S; Dai X; Li J; Lin Q; Ni D; Wang C; Wu J; Xue Y; Zhu M; Wang X; Mao J
    Int J Gen Med; 2024; 17():4711-4722. PubMed ID: 39429963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial.
    He X; Jiang Y; Li S; Liu D; Li Z; Han X; Zhang X; Dong X; Liu H; Huang J; Wang X; Long W; Ni S; Yang Z; Ye T
    Int J Gen Med; 2023; 16():6177-6188. PubMed ID: 38169574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Danshen extract on lipoprotein-associated phospholipase A
    Chen AD; Wang CL; Qin Y; Tian L; Chen LB; Yuan XM; Ma LX; Wang YF; Sun JR; Wang HS; Dai N;
    Trials; 2017 Dec; 18(1):606. PubMed ID: 29262859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao JN; Zhang Y; Lan X; Chen Y; Li J; Zhang P; Wu LQ; Jia ST; Liu Y; Xu FQ
    Medicine (Baltimore); 2019 Aug; 98(31):e16539. PubMed ID: 31374015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study.
    Wang CL; Huan N; Wang PL; Geng QS; Ma WL; Ma LH; Jiang HY; Meng XP; Zhang DW; Gou XJ; Hu DY; Chen KJ
    Chin J Integr Med; 2023 Mar; 29(3):195-204. PubMed ID: 36301456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound danshen dripping pills vs. nitrates for stable angina pectoris: a systematic review and meta-analysis.
    Zhang M; Wang W; Sun H; Zhai J; Hu Y
    Front Cardiovasc Med; 2023; 10():1168730. PubMed ID: 37283584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial.
    Huanjia G; Hairong C; Jieqin Z; Xingzhen D; Xue F; Weizhang Z; Bojun C
    Trials; 2021 May; 22(1):336. PubMed ID: 33971940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy.
    Long W; Liao H; Huang X; Liu Q; Tang Y; Lu L; Liu J; Yuan T; Ling Y; Hong Y; Duan J; Lin W; Xian S; Yang Z
    BMJ Open; 2020 Aug; 10(8):e038074. PubMed ID: 32847917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effect and mechanism of compound Danshen dripping pills on contrast-induced nephropathy after percutaneous coronary interventional.
    Fu H; Wang L; Ying S; Zhao Z; Zhang P
    Front Cardiovasc Med; 2023; 10():1211982. PubMed ID: 38124888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study.
    Wu Z; Wu D; Jiang J; Chen A; Zheng DD; Li J; Dong Y; Chen Y
    BMJ Open; 2020 May; 10(5):e034585. PubMed ID: 32423930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of Qixue Tongzhi Granule in improving the exercise capacity of stable coronary artery disease: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Chao T; Sun J; Huan N; Ge Y; Wang C
    Front Cardiovasc Med; 2023; 10():1186018. PubMed ID: 37663413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound danshen dripping pills normalize a reprogrammed metabolism of myocardial ischemia rats to interpret its time-dependent efficacy in clinic trials: a metabolomic study.
    Aa N; Guo JH; Cao B; Sun RB; Ma XH; Chu Y; Zhou SP; Aa JY; Yang ZJ; Sun H; Wang GJ
    Metabolomics; 2019 Sep; 15(10):128. PubMed ID: 31541307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS-based metabolomics reveals metabolic changes in short- and long-term administration of Compound Danshen Dripping Pills against acute myocardial infarction in rats.
    Zhang L; Wang LL; Zeng H; Li B; Yang H; Wang GJ; Li P
    Phytomedicine; 2022 Sep; 104():154269. PubMed ID: 35717805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenzhu Guanxin Recipe Granules () for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial.
    Mao S; Xu DP; Dang XJ; Li W; Wu HL
    Chin J Integr Med; 2019 Feb; 25(2):96-102. PubMed ID: 30328569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term compound danshen dripping pills therapy reduces the no-reflow phenomenon in nondiabetes mellitus patients after primary percutaneous coronary intervention for acute myocardial infarction.
    A X; Li Z; Luo W; Chai J
    Ann Palliat Med; 2020 May; 9(3):1144-1151. PubMed ID: 32498529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.